P ۱۳۹۶-۶-۷ ۱۹:۴۴:۲۵ +۰۰:۰۰

Project Description

Pap smear
Parainfluenza type 1 (PIV-1)
Parainfluenza type 2 (PIV-2)
Parainfluenza type 3 (PIV-3)
Parainfluenza type 4 (PIV-4)
ParvoVirous B19
PDGFRB(5q33) for Myeloid and Lymphoid Neoplasms with Eosinophilia (HES/CEL)
Plasma Cell Leukemia panel at diagnosis ( 12-16 CD markers)
Plasma Cell Leukemia panel for MRD ( 8-12 CD markers)
Plasma Cell Myeloma panel at diagnosis ( 12-16 CD markers)
Plasma Cell Myeloma panel for MRD ( 8-12 CD markers)
Plasminogen Activator Inhibitor-1 (PAI-1) gene 675 4G/5G
Plasminogen Activator Inhibitor-1 (PAI-1) gene 844 A/G
Plasmodium falciparum
Plasmodium vivax
Plavix or Clopidogrel resitance or Cyp2c19 Genotyping for Plavix or Clopidogrel – Genotype 2
Plavix or Clopidogrel resitance or Cyp2c19 Genotyping for Plavix or Clopidogrel – Genotype 3
PLZF-RARA
PML/RARA t(15;17)(15q24,17q21) for AML-M3
Pneumocystis jiroveci (carinii)
Pneumocystis jiroveci (carinii)
PNH Panel Granulocyte/Monocyte & Erytrocyte (10-14 CD markers)
Prothrombin (Factor II)/ G20210A Mutation